RxDoctor Payments Data

Tiana Akins, APRN

Psychiatric/Mental Health · Yuma, TNNPI 1295340826

Payments from drug & device makers

$1,735in general payments, 2019–2025

Across 96 payments — averaging $18.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$632
  • Otsuka America Pharmaceutical, Inc.$255
  • Lundbeck LLC$202
  • Johnson & Johnson$143
  • Vanda Pharmaceuticals Inc.$143
  • Neurocrine Biosciences, Inc.$118
  • plus $242 from 6 others

What the payments were for

  • Food & beverage$1,735100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,735 in reported general payments places this provider in the 65th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Medicare billing

Part B allowed, 2024
$3,260
Medicare patients
27
Services billed
55

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl14$19,952
Lurasidone Hcl12$1,644
Aripiprazole36$1,119
Quetiapine Fumarate64$1,071
Oxcarbazepine17$723
Buspirone Hcl42$568
Hydroxyzine Hcl38$516
Mirtazapine25$319
Risperidone24$306
Hydroxyzine Pamoate24$292
Venlafaxine Hcl ErVenlafaxine Hcl15$288
Olanzapine15$273
Benztropine Mesylate20$260
Clonazepam23$212
Escitalopram Oxalate17$200

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$632$19,95214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Yuma

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →